• Login
    View Item 
    •   DORA Home
    • Faculty of Health and Life Sciences
    • Leicester School of Pharmacy
    • View Item
    •   DORA Home
    • Faculty of Health and Life Sciences
    • Leicester School of Pharmacy
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Can quantitative dried blood spot analyses be an aid to medicine optimization in cardiovascular diseases?

    Thumbnail
    Date
    2015-07-03
    Author
    Bernieh, Dennis;
    Lawson, Graham;
    Tanna, Sangeeta
    Metadata
    Show attachments and full item record
    Abstract
    Introduction: Over 355 million prescriptions were dispensed for cardiovascular diseases in the UK in 2013 [1]. Half of these, costing the NHS £2.3 billion, were wasted because patients do not take their medicines as prescribed [2]. A method using dried blood spot (DBS) sample collection followed by liquid chromatography-high resolution mass spectrometry (LC-HRMS) [3] was developed and validated for quantification of eleven commonly UK prescribed cardiovascular drugs: amlodipine, atenolol, atorvastatin, bisoprolol, diltiazem, doxazosin, lisinopril, losartan, ramipril, simvastatin and valsartan. Thus medication efficiency, adherence or drug/drug interactions can be assessed from reference pharmacokinetic data. Methods: For the preparation of DBS calibration samples whole blood was spiked with eleven target analytes to produce 30µl blood spots on specimen cards. 8mm disc was punched out and extracted with methanol:water (70:30v/v) containing the internal standard, atenolol D7. Chromatography analysis was performed using gradient elution with a run time of 2.5 min. MS detection was carried out in electrospray positive ion mode for all target analytes and internal standard. Results: The LC-HRMS method showed good linearity and the accuracy (relative error) and precision (coefficient of variation) values were within the pre-defined limits of ≤15% at all tested concentrations for eight of the target drugs. Drug recoveries from spiked blood spots were ≥ 82% for atenolol, bisoprolol, diltiazem, doxazosin, losartan, ramipril and valsartan. Results from volunteers were within expected levels except where elevated levels indicated a recognised drug/drug interaction. Conclusions: Quantitative DBS analyses can be used as a means to optimize medication for heart disease patients.
    Description
    Citation : Bernieh, D., Lawson, G. and Tanna, S. (2015) Can quantitative dried blood spot analyses be an aid to medicine optimization in cardiovascular diseases? Proceedings of the Analytical Research Forum (ARF) 2015
    URI
    http://hdl.handle.net/2086/11206
    Research Group : Pharmacy Practice
    Research Institute : Leicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)
    Peer Reviewed : Yes
    Collections
    • Leicester School of Pharmacy [1213]

    Submission Guide | Reporting Guide | Reporting Tool | DMU Open Access Libguide | Take Down Policy | Connect with DORA
    DMU LIbrary
     

     

    Browse

    All of DORACommunities & CollectionsAuthorsTitlesSubjects/KeywordsResearch InstituteBy Publication DateBy Submission DateThis CollectionAuthorsTitlesSubjects/KeywordsResearch InstituteBy Publication DateBy Submission Date

    My Account

    Login

    Submission Guide | Reporting Guide | Reporting Tool | DMU Open Access Libguide | Take Down Policy | Connect with DORA
    DMU LIbrary